HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kazuo Tajima Selected Research

ORALIT (ORS)

1/2014Intake of freshwater fish and associated fatty acids and risk of breast cancer.
7/2013The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer.
11/2012Time to first cigarette and upper aerodigestive tract cancer risk in Japan.
8/2011No association between angiotensin I converting enzyme (ACE) I/D polymorphism and gastric cancer risk among Japanese.
2/2011Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.
1/2011Physiological, reproductive factors and breast cancer risk in Jiangsu province of China.
11/2010No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese.
6/2010Relationship between serum levels of insulin-like growth factors and subsequent risk of cancer mortality: findings from a nested case-control study within the Japan Collaborative Cohort Study.
5/2010Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study.
5/2010Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kazuo Tajima Research Topics

Disease

58Neoplasms (Cancer)
01/2015 - 01/2002
28Breast Neoplasms (Breast Cancer)
01/2015 - 01/2002
17Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 04/2002
17Stomach Neoplasms (Stomach Cancer)
07/2013 - 01/2002
13Lung Neoplasms (Lung Cancer)
06/2015 - 04/2002
8Atrophy
08/2011 - 01/2003
8Infection
02/2011 - 05/2002
7Colonic Neoplasms (Colon Cancer)
05/2011 - 01/2005
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014 - 01/2006
5Esophageal Neoplasms (Esophageal Cancer)
07/2005 - 12/2002
5Lymphoma (Lymphomas)
06/2005 - 02/2003
4Rectal Neoplasms (Rectal Cancer)
01/2012 - 03/2002
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2011 - 10/2008
4Endometrial Neoplasms (Endometrial Cancer)
01/2011 - 03/2007
3Adenocarcinoma
10/2014 - 12/2009
3Inflammation
01/2014 - 04/2003
3Duodenal Ulcer (Curling's Ulcer)
01/2013 - 07/2006
3Macular Degeneration (Age-Related Maculopathy)
02/2012 - 11/2010
3Carcinoma (Carcinomatosis)
02/2009 - 01/2003
2Rheumatoid Arthritis
01/2012 - 12/2011
2Obesity
01/2011 - 05/2010
2Flushing
08/2010 - 05/2006
2Small Cell Carcinoma
12/2009 - 08/2007
2Gallbladder Neoplasms (Gallbladder Cancer)
12/2009 - 12/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2007 - 01/2007
2Cervical Intraepithelial Neoplasia
10/2004 - 04/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2014
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2014
1Neoplasm Metastasis (Metastasis)
07/2014

Drug/Important Bio-Agent (IBA)

32ORALIT (ORS)IBA
01/2014 - 02/2002
14Folic Acid (Vitamin M)FDA LinkGeneric
07/2013 - 02/2003
10EnzymesIBA
09/2009 - 01/2003
9Insulin-Like Growth Factor I (IGF-1)IBA
01/2011 - 07/2003
7carbonyl reductase (NADPH)IBA
06/2015 - 03/2009
7Estrogens (Estrogen)FDA Link
01/2015 - 10/2002
7Fatty Acids (Saturated Fatty Acids)IBA
01/2014 - 01/2005
7Thymidylate SynthaseIBA
01/2012 - 02/2003
7Biological Markers (Surrogate Marker)IBA
01/2012 - 05/2002
7Insulin (Novolin)FDA Link
12/2011 - 07/2003
6Aldehyde DehydrogenaseIBA
07/2013 - 03/2002
6AntigensIBA
01/2013 - 01/2008
6Insulin-Like Growth Factor Binding Protein 3IBA
06/2010 - 12/2009
6Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
05/2010 - 04/2004
5HormonesIBA
01/2011 - 01/2002
5Insulin-Like Growth Factor II (Somatomedin A)IBA
06/2010 - 12/2009
5Cytochrome P-450 CYP2E1 (CYP2E1)IBA
09/2009 - 01/2002
5CarbonIBA
10/2008 - 12/2005
4AcetaldehydeIBA
07/2013 - 07/2005
4CalciumIBA
05/2010 - 07/2004
4Superoxide DismutaseIBA
12/2009 - 12/2009
4Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2007 - 01/2003
3benzoquinone (quinone)IBA
06/2015 - 04/2002
3SmokeIBA
05/2015 - 02/2003
3TeaIBA
07/2014 - 12/2002
3OxidoreductasesIBA
07/2014 - 03/2009
3Codon (Codons)IBA
01/2014 - 01/2003
3lysyllysine (Lys-Lys)IBA
07/2013 - 03/2002
3glutamyl-glutamic acid (Glu-Glu)IBA
07/2013 - 03/2002
3Somatomedins (Somatomedin)IBA
06/2010 - 07/2003
3Aldehyde Reductase (Aldose Reductase)IBA
01/2010 - 07/2009
3AntioxidantsIBA
12/2009 - 07/2004
3Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
11/2009 - 05/2007
35-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA
10/2008 - 12/2004
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
10/2008 - 01/2007
3DNA (Deoxyribonucleic Acid)IBA
04/2007 - 05/2002
3Lymphotoxin-alpha (Lymphotoxin)IBA
03/2007 - 01/2005
38-hydroxyguanineIBA
05/2003 - 05/2002
2Growth Hormone (Somatotropin)IBA
01/2015 - 03/2010
2Tobacco Smoke Pollution (Passive Smoking)IBA
10/2014 - 01/2013
2Messenger RNA (mRNA)IBA
07/2014 - 09/2008
2CoffeeFDA Link
07/2014 - 03/2007
2HLA-DRB1 antigen (HLA DRB1)IBA
01/2012 - 12/2011
2Toll-Like Receptor 4IBA
04/2011 - 02/2009
2PepsinogensIBA
04/2011 - 01/2009
2Progesterone Receptors (Progesterone Receptor)IBA
05/2010 - 10/2008
2Superoxides (Superoxide)IBA
12/2009 - 12/2009
2Carotenoids (Carotene)IBA
12/2009 - 05/2006
2cysteinylcysteineIBA
12/2009 - 06/2002
2Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2009 - 03/2005
2Arachidonic Acid (Vitamin F)IBA
12/2008 - 10/2006
2methionine synthase reductaseIBA
10/2008 - 08/2007
2LigandsIBA
09/2008 - 02/2008
2Interleukin-1beta (Interleukin 1 beta)IBA
03/2006 - 01/2006
2Environmental CarcinogensIBA
01/2006 - 05/2002
2CarcinogensIBA
05/2005 - 01/2002
2NAD (NADH)IBA
02/2005 - 04/2002
2oxidized low density lipoproteinIBA
01/2005 - 01/2005
2VaccinesIBA
10/2004 - 04/2003
2Aromatase (CYP19)IBA
08/2004 - 05/2002
2InterleukinsIBA
04/2003 - 10/2002
12-tert-butylhydroquinone (tert-butylhydroquinone)IBA
06/2015
1QuinonesIBA
06/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2014
1Acetylcysteine (Siran)FDA LinkGeneric
07/2014
19,10-phenanthrenequinoneIBA
07/2014
1Adiponectin ReceptorsIBA
01/2014
1AdiponectinIBA
01/2014

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2015 - 01/2006
1Adjuvant Chemotherapy
01/2015
1Exercise Therapy (Therapy, Exercise)
07/2013